Yun Rhie, Minwoo Jung, and Minjun Kim - WittGen Bio episode artwork

EPISODE · Sep 21, 2022 · 42 MIN

Yun Rhie, Minwoo Jung, and Minjun Kim - WittGen Bio

from Angel Invest Boston · host Sal Daher, CFA - Angel Invest Boston

Angel Scale Biotech: Learn More Yun Rhie, Minwoo Jung, and Minjun Kim are the founders of WittGen. The company is working with AI to create a more efficient platform for treating cancer, a field which tends to have a lower treatment success rate due to its complexity. Sponsored by Purdue University entrepreneurship and Peter Fasse, patent attorney at Fish and Richardson. Highlights: Sal Daher Introduces Yun Rhie, Minwoo Jung, and Minjun Kim "... The problem you have is that you have to figure out what kind of a tumor you have in order to treat it, to have the right medication to treat it...." Looking Ahead at What's to Come for WittGen "... Using sequencing of the RNA, which tells you what genes are being expressed and being triggered, and then you can look at that and then compare that to samples of the cells, looked at in the microscope and so on..." What Sets WittGen Apart How the Team Came to Be Topics: robotics/AI, biotech, founding stories

Episode metadata supplied by the publisher feed · Published Sep 21, 2022

Embed this episode

NOW PLAYING

Yun Rhie, Minwoo Jung, and Minjun Kim - WittGen Bio

0:00 42:01

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

No similar episodes found.

No similar podcasts found.

Frequently Asked Questions

How long is this episode of Angel Invest Boston?

This episode is 42 minutes long.

When was this Angel Invest Boston episode published?

This episode was published on September 21, 2022.

Can I download this Angel Invest Boston episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!